Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Lendvai N, Sborov D, Suvannasankha A, Weisel K, Karlin L, Libby E, Arnulf B, Facon T, Hulin C, Kortüm KM, Rodríguez-Otero P, Usmani SZ, Hari P, Baz R, Quach H, Moreau P, Voorhees PM, Gupta I, Hoos A, Zhi E, Baron J, Piontek T, Lewis E, Jewell RC, Dettman EJ, Popat R, Esposti SD, Opalinska J, Richardson P, Cohen AD. Lonial S, et al. Among authors: nooka ak. Lancet Oncol. 2020 Feb;21(2):207-221. doi: 10.1016/S1470-2045(19)30788-0. Epub 2019 Dec 16. Lancet Oncol. 2020. PMID: 31859245 Clinical Trial.
Supportive therapies in multiple myeloma.
Gleason C, Nooka A, Lonial S. Gleason C, et al. J Natl Compr Canc Netw. 2009 Oct;7(9):971-9. doi: 10.6004/jnccn.2009.0064. J Natl Compr Canc Netw. 2009. PMID: 19878640 Review.
Improving induction therapy in multiple myeloma.
Nooka A, Gleason C, Lonial S. Nooka A, et al. Curr Hematol Malig Rep. 2010 Jul;5(3):119-28. doi: 10.1007/s11899-010-0057-7. Curr Hematol Malig Rep. 2010. PMID: 20449692 Review.
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.
Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston AA, Heffner LT, Torre C, McMillan S, Renfroe H, Harvey RD, Lechowicz MJ, Khoury HJ, Flowers CR, Waller EK. Lonial S, et al. Clin Cancer Res. 2010 Oct 15;16(20):5079-86. doi: 10.1158/1078-0432.CCR-10-1662. Epub 2010 Aug 25. Clin Cancer Res. 2010. PMID: 20739431 Clinical Trial.
Temporal changes in plerixafor administration and hematopoietic stem cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
Harvey RD, Kaufman JL, Johnson HR, Nooka A, Vaughn L, Flowers CR, Khoury HJ, Lechowicz MJ, Langston AA, Lonial S, Waller EK. Harvey RD, et al. Biol Blood Marrow Transplant. 2013 Sep;19(9):1393-5. doi: 10.1016/j.bbmt.2013.06.003. Epub 2013 Jun 10. Biol Blood Marrow Transplant. 2013. PMID: 23764455 Free article. Clinical Trial.
188 results